4-(2,1,3-Benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester
3D model (JSmol)
CompTox Dashboard (EPA)
|Molar mass||371.393 g·mol−1|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Darodipine is an experimental calcium channel blocker that based on animal models may reduce neuronal cytoskeletal alterations during aging and in neurodegenerative disorders.<ref>Amenta, Francesco; Ferrante, Fabio; Mancini, Maurizio; Sabbatini, Maurizio; Vega, Joséantonio; Zaccheo, Damiano (1995). "Effect of long term treatment with the dihydropyridine-type calcium channel blocker darodipine (PY 108-068) on the cerebral capillary network in aged rats". Mechanisms of Ageing and Development. 78: 27–37. doi:10.1016/0047-6374(94)01513-L.
|This biochemistry article is a stub. You can help Wikipedia by expanding it.|